State of Wyoming Takes Position in Envista Holdings Corporation $NVST

State of Wyoming acquired a new stake in Envista Holdings Corporation (NYSE:NVST) in the second quarter, HoldingsChannel.com reports. The firm acquired 26,457 shares of the company’s stock, valued at approximately $697,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. GSA Capital Partners LLP acquired a new stake in Envista in the 2nd quarter worth about $2,039,000. Legacy Wealth Asset Management LLC acquired a new position in shares of Envista during the 2nd quarter valued at about $200,000. Edgestream Partners L.P. acquired a new position in shares of Envista during the 1st quarter valued at about $2,619,000. Amundi lifted its holdings in shares of Envista by 8.7% during the 1st quarter. Amundi now owns 184,575 shares of the company’s stock worth $4,683,000 after acquiring an additional 14,739 shares during the period. Finally, California State Teachers Retirement System lifted its holdings in shares of Envista by 22.6% during the 1st quarter. California State Teachers Retirement System now owns 194,212 shares of the company’s stock worth $4,927,000 after acquiring an additional 35,848 shares during the period.

Envista Stock Performance

Envista stock opened at $28.05 on Monday. Envista Holdings Corporation has a 12-month low of $18.77 and a 12-month high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The company has a market capitalization of $4.50 billion, a price-to-earnings ratio of 48.35, a price-to-earnings-growth ratio of 1.34 and a beta of 0.86. The firm’s fifty day moving average price is $26.57 and its 200 day moving average price is $26.17.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. The company had revenue of $730.50 million during the quarter, compared to analysts’ expectations of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, research analysts forecast that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on NVST. BMO Capital Markets started coverage on shares of Envista in a report on Wednesday, July 8th. They issued a “market perform” rating and a $27.00 target price for the company. Morgan Stanley set a $23.00 price target on shares of Envista in a research note on Thursday, August 6th. Mizuho set a $29.00 price objective on shares of Envista in a research note on Thursday, August 6th. Zacks Research upgraded Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Finally, Barclays cut their target price on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research report on Thursday, June 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $29.31.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.